Hyaluronic acid fillers are used for undereye volume correction, detailing aging effects on facial anatomy, common ...

Neffy, a new epinephrine nasal spray, offers a less invasive option for treating allergic reactions. Learn about its benefits ...

Korean drugmaker Celltrion plans to achieve annual sales of 5 trillion won ($3.58 billion) next year, driven by the growth of ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved HYMPAVZI™ (marstacimab-hncq) for routine ...

into subcutaneous and abdominal injections, respectively, to evaluate the effectiveness of atopic dermatitis treatment. As a ...

In a randomized controlled trial of people with type 2 diabetes, albuminuria, and estimated glomerular filtration rate (eGFR) ...

The request is based on findings from the Phase III ASTRO study, which achieved the primary endpoint of clinical remission at ...

While each of us should aim to be fit as a fiddle, how we achieve our fitness goals is the real question. With Ozempic and ...

New research highlights the potential for weight-loss medication to ease arthritis symptoms, offering hope for improved mobility and pain relief. In a recent study published in The New England Journal ...

A subcutaneous version of Merck’s Keytruda was as effective as the infused version in a late-stage study, but the company won ...

The GLP-1 receptor agonist improved both histology and fibrosis in patients, with additional improvements in their liver ...

Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has granted marketing authorization for HYMPAVZI™ (marstacimab) for the ...